What Audentes Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Holles Natalie C. | President and COO | Jan 15 | Tender Offer · U | −104,439 | $60.00 | −$6.27M | 0 |
| Patterson Matthew R | Chief Executive Officer | Jan 15 | Tender Offer · U | −171,814 | $60.00 | −$10.3M | 0 |
| Patterson Matthew R | Chief Executive Officer | Jan 15 | Tender Offer · U | −261,458 | $60.00 | −$15.7M | 0 |
| Goldberg Mark Alan | Director | Jan 15 | Tender Offer · U | −1,500 | $60.00 | −$90K | 0 |
| Meltz Mark A | SVP, General Counsel | Jan 15 | Tender Offer · U | −32,705 | $60.00 | −$1.96M | 0 |
| Mosbrooker Eric | SVP, Chief Commercial Officer | Jan 15 | Tender Offer · U | −26,919 | $60.00 | −$1.62M | 0 |
| Schuetz Thomas J. | Director | Jan 15 | Tender Offer · U | −89,695 | $60.00 | −$5.38M | 0 |
| Lange Louis G | Director | Jan 15 | Tender Offer · U | −3,555 | $60.00 | −$213K | 0 |
| Lange Louis G | Director | Jan 15 | Tender Offer · U | −32,343 | $60.00 | −$1.94M | 0 |
| Lange Louis G | Director | Jan 15 | Tender Offer · U | −265,799 | $60.00 | −$15.9M | 0 |
| Lange Louis G | Director | Jan 15 | Tender Offer · U | −13,678 | $60.00 | −$821K | 0 |
| Soloway Thomas P | Executive Vice President, CFO | Jan 15 | Tender Offer · U | −183,384 | $60.00 | −$11M | 0 |
| Conner Edward R. | SVP, Chief Medical Officer | Jan 15 | Tender Offer · U | −24,584 | $60.00 | −$1.48M | 0 |
| Patterson Matthew R | Chief Executive Officer | Jan 08 | Exercise / conversion · M | +11,666 | $15.26 | +$178K | 261,458 |
| Patterson Matthew R | Chief Executive Officer | Jan 08 | Exercise / conversion · M | +11,824 | $9.50 | +$112K | 249,792 |
| Patterson Matthew R | Chief Executive Officer | Jan 08 | Exercise / conversion · M | +74,297 | $2.19 | +$163K | 237,968 |
| Patterson Matthew R | Chief Executive Officer | Jan 08 | Exercise / conversion · M | +64,751 | $0.78 | +$50.5K | 163,671 |
| Soloway Thomas P | Executive Vice President, CFO | Jan 08 | Exercise / conversion · M | +6,219 | $15.26 | +$94.9K | 183,384 |
| Soloway Thomas P | Executive Vice President, CFO | Jan 08 | Exercise / conversion · M | +144,669 | $2.76 | +$400K | 177,165 |
| Patterson Matthew R | Chief Executive Officer | Dec 26 | Gift · G | −12,500 | — | — | 98,920 |
Loading...
